Bacteriophages, or phages (bacterial viruses), have seen a resurgence in their applications following the emergence of antimicrobial-resistant superbugs that pose enormous risks to human health and food supplies. Phages present numerous advantages over conventional small-molecule antibiotics, including that they are highly selective bacteria-killers and demonstrate low inherent cytotoxicity to human health. Notwithstanding the direct therapeutic applications of these innate bacteria-killing viruses, they have also garnered attention as biological nanoparticles. Due to the diversity in sizes and shapes of phages, self-replicating capacity, geometrical batch-to-batch consistency, and ease of synthetic modifications, phages are excellent building blocks for creating bioactive biomaterial platforms. In this review, we provide a brief history of the development of phage-based materials and identify key stakeholders who are driving innovation in this space. In addition, we explore various phage-based gel structures and provide a critical analysis of how their structures produce distinct advantageous properties that can be exploited for applications in solving challenges in biomedical engineering.